Exact Mass: 686.5696

Exact Mass Matches: 686.5696

Found 45 metabolites which its exact mass value is equals to given mass value 686.5696, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CE(20:4(6E,8Z,11Z,14Z)+=O(5))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoate

C47H74O3 (686.5638)


CE(20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(6E,8Z,11Z,14Z)+=O(5)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,13E)+=O(15))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoate

C47H74O3 (686.5638)


CE(20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,13E)+=O(15)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoate

C47H74O3 (686.5638)


CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C47H74O3 (686.5638)


CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C47H74O3 (686.5638)


CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C47H74O3 (686.5638)


CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

9-Methyltetradecanoylcrasseride

9-Methyltetradecanoylcrasseride

C40H78O8 (686.5696)


   

13-Methyltetradecanoylcrasseride

13-Methyltetradecanoylcrasseride

C40H78O8 (686.5696)


   

1-O-alpha-D-glucopyranosyl-(2-tetradecanoyloxy)-eicosan-1-ol

1-O-alpha-D-glucopyranosyl-(2-tetradecanoyloxy)-eicosan-1-ol

C40H78O8 (686.5696)


   

Crasseride 2

1-O-(1S,2S,3R,4R,5S-tetrahydroxycyclopentyl)-2-(9-methyl-tetradecanoyl)-3-(10-methyl-hexadecanyl)-sn-glycerol

C40H78O8 (686.5696)


   

Crasseride 3

1-O-(1S,2S,3R,4R,5S-tetrahydroxycyclopentyl)-2-(13-methyl-tetradecanoyl)-3-(10-methyl-hexadecanyl)-sn-glycerol

C40H78O8 (686.5696)


   

Crasseride 4

1-O-(1S,2S,3R,4R,5S-tetrahydroxycyclopentyl)-2-(12-methyl-tetradecanoyl)-3-(10-methyl-hexadecanyl)-sn-glycerol

C40H78O8 (686.5696)


   

CE(20:4(6E,8Z,11Z,14Z)+=O(5))

CE(20:4(6E,8Z,11Z,14Z)+=O(5))

C47H74O3 (686.5638)


   

CE(20:4(5Z,8Z,11Z,13E)+=O(15))

CE(20:4(5Z,8Z,11Z,13E)+=O(15))

C47H74O3 (686.5638)


   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C47H74O3 (686.5638)


   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C47H74O3 (686.5638)


   

CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C47H74O3 (686.5638)


   

CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C47H74O3 (686.5638)


   

NAOrn 24:4/13:0

NAOrn 24:4/13:0

C42H74N2O5 (686.5597)


   

NAOrn 13:0/24:4

NAOrn 13:0/24:4

C42H74N2O5 (686.5597)


   

NAOrn 26:4/11:0

NAOrn 26:4/11:0

C42H74N2O5 (686.5597)


   

NAOrn 22:3/15:1

NAOrn 22:3/15:1

C42H74N2O5 (686.5597)


   

NAOrn 17:2/20:2

NAOrn 17:2/20:2

C42H74N2O5 (686.5597)


   

NAOrn 18:2/19:2

NAOrn 18:2/19:2

C42H74N2O5 (686.5597)


   

NAOrn 20:4/17:0

NAOrn 20:4/17:0

C42H74N2O5 (686.5597)


   

NAOrn 18:3/19:1

NAOrn 18:3/19:1

C42H74N2O5 (686.5597)


   

NAOrn 15:0/22:4

NAOrn 15:0/22:4

C42H74N2O5 (686.5597)


   

NAOrn 21:1/16:3

NAOrn 21:1/16:3

C42H74N2O5 (686.5597)


   

NAOrn 16:4/21:0

NAOrn 16:4/21:0

C42H74N2O5 (686.5597)


   

NAOrn 11:0/26:4

NAOrn 11:0/26:4

C42H74N2O5 (686.5597)


   

NAOrn 18:4/19:0

NAOrn 18:4/19:0

C42H74N2O5 (686.5597)


   

NAOrn 15:1/22:3

NAOrn 15:1/22:3

C42H74N2O5 (686.5597)


   

NAOrn 16:2/21:2

NAOrn 16:2/21:2

C42H74N2O5 (686.5597)


   

NAOrn 21:2/16:2

NAOrn 21:2/16:2

C42H74N2O5 (686.5597)


   

NAOrn 17:0/20:4

NAOrn 17:0/20:4

C42H74N2O5 (686.5597)


   

NAOrn 20:3/17:1

NAOrn 20:3/17:1

C42H74N2O5 (686.5597)


   

NAOrn 22:4/15:0

NAOrn 22:4/15:0

C42H74N2O5 (686.5597)


   

NAOrn 17:1/20:3

NAOrn 17:1/20:3

C42H74N2O5 (686.5597)


   

NAOrn 24:3/13:1

NAOrn 24:3/13:1

C42H74N2O5 (686.5597)


   

NAOrn 19:2/18:2

NAOrn 19:2/18:2

C42H74N2O5 (686.5597)


   

NAOrn 16:3/21:1

NAOrn 16:3/21:1

C42H74N2O5 (686.5597)


   

NAOrn 19:1/18:3

NAOrn 19:1/18:3

C42H74N2O5 (686.5597)


   

NAOrn 20:2/17:2

NAOrn 20:2/17:2

C42H74N2O5 (686.5597)